Announcements

Home > Investor Relations >Announcements
Back List
The board of directors resolved to acquire securities date : 2020/11/27

SEQ_NO

1

Date of announcement

2020/11/27

Time of announcement

18:23:14

Spokesman:

WANG,KUAN-CHIEH

Title of Spokesman:

Finance Manager

Subject

The board of directors resolved to acquire securities.

To which item it meets

paragraph 20

Date of events

2020/11/27

Statement

1.Name of the securities:CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.

2.Trading date:2020/11/27

3.Amount, unit price, and total monetary amount of the transaction:

   Total monetary amount: No more than NT$ 400,000,000

4.Gain (or loss) through disposal (not applicable in case of acquisition of

securities):NA

5.Relationship with the underlying company of the trade:

   CCSB is the Company's investment using the equity method of accounting.

6.Current cumulative amount held, monetary amount, and shareholding

   percentage of cumulative holdings of the securities being traded (including

   the current trade), and status of any restriction of rights (e.g.pledges):

   The actual transaction information will be announced in accordance with

   the provisions of Regulations Governing the Acquisition and Disposal of

   Assets by Public Companies .

7.Current ratio of securities investment (including the current trade, as

   listed in article 3 of Regulations Governing the Acquisition and Disposal of

   Assets by Public Companies) to the total assets and equity attributable to

   owners of the parent as shown in the most recent financial statement and

   working capital as shown in the most recent financial statement as of the

   present:

   Ratio to the total assets and shareholder's equity: The actual transaction

   information will be announced in accordance with the provisions of

   Regulations Governing the Acquisition and Disposal of Assets by Public

   Companies .

   The operational capital as shown in the most recent financial statement:

   NT$ 84,403thousand

8.Concrete purpose of the acquisition or disposal:Strategic investment

9.Any dissenting opinions of directors to the present transaction:No

10.Whether the counterparty of the current transaction is a related party:

      No

11.Trading counterparty and its relationship with the Company:NA

12.Date of the board of directors resolution:2020/11/27

13.Date of ratification by supervisors or approval by

     the audit committee:2020/11/27

14.Any other matters that need to be specified:

     The actual transaction information will be announced in accordance with

     the provisions of Regulations Governing the Acquisition and Disposal of

     Assets by Public Companies .